CD24Fc: an emerging COVID-19 therapy.

Eckhardt, Christina M; O'Donnell, Max R

Eckhardt, Christina M; O'Donnell, Max R.

Eckhardt CM; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: cme2113@cumc.columbia.edu.
O'Donnell MR; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Epidemiology, Columbia University Irving Medical Center, New York, NY 10032, USA.

Lancet Infect Dis ; 22(5): 565-567, 2022 05.

Article in English | MEDLINE | ID: covidwho-1967530

Subject(s)

COVID-19; Humans; Immunologic Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google